Top 50 Health Care VC (Venture Capital) Funds in United Kingdom in January 2026

Investor	Health Care United Kingdom investments
Parkwalk Advisors	60
UK Innovation & Science Seed Fund	59
Oxford Science Enterprises	48
Deepbridge Capital	46
Development Bank of Wales	44
Oxford Technology Management	44
Scottish Enterprise	42
Mercia Fund Managers	40
Scottish Investment Bank	37
Catapult Ventures	35
Oxford Science Enterprises	34
SOSV	33
Business Growth Fund	33
Northstar Ventures	32
AlbionVC	32
SyndicateRoom	32
SFC Capital	31
Cambridge Angels group	28
IP Group	27
Newable Private Investing	26
Octopus Ventures	26
Calm/Storm Ventures	25
Mercia Asset Management	24
Future Planet Capital	24
Archangels	24
Kindred Capital	23
Ascension	23
Oxford Capital	23
Techstart Ventures	22
Kelvin Capital	22
24 Haymarket	21
Innovate UK	21
Salica	21
GM&C Life Sciences Fund	21
Epidarex Capital	21
Cambridge Innovation Capital	20
Downing Ventures	20
Foresight Group	19
Praetura Ventures	19
Hoxton Ventures	19
Wren Capital	18
Sofinnova Partners	18
Midlands Engine Investment Fund	18
The FSE Group	18
TRICAPITAL	18
IQ Capital	17
Clarendon Fund Managers	17
Midven	16
Longwall Venture	16
Syncona Partners LLP	16

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Series B
United Kingdom, United States, Philippines

Portfolio highlights

Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

MFX — MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies.
Astut — Astut revolutionizes AI for high stakes unseen decisions.
Pencil Biosciences — Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to overcome the limitations of current technologies.

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Series B
United Kingdom, United States, Finland

Portfolio highlights

Kneu Health — Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Oath Surgical — High quality outpatient surgical care. That's our Oath. Oath provides patients with access to high quality, lower cost surgical care in premium and convenient outpatient settings.
Wild Bioscience — Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Australia, Singapore

Portfolio highlights

AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Debt Financing
United Kingdom, Australia, United States

Portfolio highlights

Biomonde — Back to basics with a modern twist. Live larvae can be used to clean non-healing or infected wounds in a gentle, non-invasive sealed bag.
Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
ADC Biotechnology — Temukan prediksi Macau 4D 5D akurat di situs kami! Dapatkan bocoran togel toto Prediksi Macau Hari ini, dirumuskan oleh master prediktor. Bandingkan analisa Anda dan manfaatkan prediksi kami untuk meningkatkan peluang kemenangan Anda. Bergabunglah dengan kami untuk meraih JP impian. Salam JP

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

OxCan — Enabling curative cancer treatment through early detection
CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Investment focus

Biotechnology, Software, Health Care
Seed, Grant, Funding Round
United Kingdom, United States, Japan

Portfolio highlights

Swurf — The work surfing platform. Making it easy for venues to welcome a new community of remote workers.
Gigged.AI — Fill skill gaps using our on-demand talent network. Get AI-powered, real-time visibility over your employee and agent capabilities to power internal mobility.
Bright Ascension — Bright Ascension offers mission ready software in space and on the ground. Our integrated software is perfect for any satellite mission.

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Hungary

Portfolio highlights

Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Warwick Acoustics — Warwick Acoustics believe in creating products that are designed from the ground up in order to deliver the best personal audio listening experience available to customers.
Melius Cyber — Melius Cyber continuously monitors an organization's IT network, testing security and protecting it from the latest threats.

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Investment focus

Software, Biotechnology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Investment focus

Health Care, Biotechnology, Software
Series A, Seed, Series B
United Kingdom, United States, The Netherlands

Portfolio highlights

FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Private Equity
United Kingdom, Ireland, United States

Portfolio highlights

Jola — Jola provides broadband, ethernet leased lines, hosted telephony, ISDN replacement, calls & lines and Mobile SIMs to UK SMEs via Partners.
Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Investment focus

Software, Health Care, E-Commerce
Seed, Funding Round, Series A
United Kingdom, United States, Indonesia

Portfolio highlights

Nanovery — Founded by scientists specialised in Nanotechnology, Medicinal Chemistry and Artificial Intelligence, we are on a mission to enable early detection of cancer through a rapid and affordable blood test Backed by academics at top universities, clinicians, industrial leaders, and Entrepreneur First.
AI Hay — AI Hay develops an AI-driven answer engine that allows users to access information through a question-and-answer format. The company combines hyperlocal, culturally nuanced knowledge discovery engines with social loops to enhance community validation and perspectives. It utilizes in-house specialized large-language models, retrieval-augmentedgeneration (RAG), and social features to build a knowledge discovery platform that serves the community.
Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Investment focus

Software, Information Technology, Health Care
Series A, Funding Round, Seed
United Kingdom, United States, France

Portfolio highlights

Kohort — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
Agio Ratings — Agio enables firms that trade and invest in digital assets to protect capital, underwrite credit, and secure long-term success
OpenTrade — OpenTrade providers web3 treasurers, institutions, and accredited investors access to on-chain structured financial products backed by investment grade RWAs.

SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.

Investment focus

Health Care, Software, Medical
Seed, Equity Crowdfunding, Funding Round
United Kingdom, United States, India

Portfolio highlights

Roomix — Make your home your own with Roomix. Get custom made products from expert joiners along with installation instructions and on-hand support. Floor Beds, wall panelling, shelving, radiator covers and lots more.
OVA — OVA is a reproductive health brand designed to support both men and women on their fertility journeys.
Noggin HQ — The next generation of credit referencing is coming. Look busy.

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

TILKI — TILKI is an AI-powered game creation platform that democratizes video game development by enabling all creators to build immersive games without coding.
ZERØTEC — ZERØTEC is an pattern design and nesting software platform for fashion designers and manufacturers
Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Estonia

Portfolio highlights

FLIT — Unfold Your Next Adventure. Discover the compact folding electric bike purpose-built for commuters, urban explorers and weekend tourers.
Wilder Sensing — Wilder Sensing analyses audio and other data sources to produce actionable insights into the status and trends of biodiversity on your site.
AVIEL Intelligence — Prevent APP fraud with the highest quality of intelligence. Use AVIEL intelligence to help prevent your customers making payments to scammers - and from receiving payments related to scams.

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Investment focus

Health Care, Biotechnology, Information Technology
Seed, Series A, Funding Round
United Kingdom, United States, Australia

Portfolio highlights

Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
Elemendar — Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information.
NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Investment focus

Software, Health Care, Information Technology
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Baselime — Use logs, metrics, distributed tracing and wide-events to detect, diagnose and resolve issues before they impact your users.
Rekord — The AI-native platform to design, scale and monitor intelligent decision flows across underwriting, onboarding, compliance and fraud.
Zendo Energy — Zendo Energy is dedicated to the mission of decarbonising computing power. The company aims to empower data centres to become smarter, more efficient, and prepared for the increasing future demand of computing by leveraging advanced software solutions. Their platform utilizes real-time analytics and predictive tools to optimise energy consumption,reduce emissions, and integrate renewable energy sources such as wind and solar, thereby supporting the transition to sustainable digital infrastructure. This mission addresses the urgent need to reduce the carbon footprint of data centres amid the exponential growth of AI and computing workloads globally

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Investment focus

Health Care, Wellness, Software
Seed, Pre-Seed, Series A
United Kingdom, Germany, Austria

Portfolio highlights

aiomics — Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.
ThinkSono — ThinkSono is a company at the cutting edge of medicine and technology.
Nolea Health — As a clinician with Nolea you can set your own schedule, work with as many healthcare companies as you want, hold all of your credentials in one single sharable wallet, access new educational resources, and receive community feedback.

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Information Technology, Manufacturing
Funding Round, Series A, Seed
United Kingdom, United States

Portfolio highlights

Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
Semble — The integrated clinical system for managing your patients' medical data and admin tasks.
Locate Bio — Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs.

Brilliant Ideas. Brilliant People. Brilliant Minds.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Convertible Note
United Kingdom, United States, Canada

Portfolio highlights

SugaROx — Discover SugaROx, pioneers in biostimulant technology. Boosting crop resilience, and yield with their science-backed agricultural solutions.
Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
Inicio AI — A specialist Income & Expenditure trained virtual agent delivering improved CX and robust results

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Investment focus

Software, Biotechnology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
United Kingdom, United States, Germany

Portfolio highlights

Hofy — Use Hofy's equipment management platform to remotely supply, manage and maintain subscription workstations, while staying compliant.
Mojo — Join 600,000+ men worldwide using AI-powered coaches to build a performance mindset and take back control of their love lives.
Sohar Health — Streamline patient intake and boost revenue with Sohar's real-time insurance verification and eligibility solutions. Automate workflows, reduce claim denials, and improve conversion rates with accurate, fast, and reliable tools. Book a demo today to transform your patient onboarding process.

Ascension is an early-stage VC built by exited entrepreneurs to back the next generation of tech and impact founders.Run by an experienced and diverse team of successful entrepreneurs, we have been relentlessly dedicated to finding the UK’s best Seed-stage startups since 2014.Ascension benefits from the active industry connections essential forthe sourcing and development of deal-flow and due diligence. The team has co-invested with the UK’s leading angels and VCs, key to securing follow-on funding as the portfolio businesses move to their next stage of growth.We believe in building an inclusive, community driven brand that can benefit the wider UK tech ecosystem and strive to work with conviction, integrity, humour, and humility.

Investment focus

Software, FinTech, Financial Services
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Italy

Portfolio highlights

Sprive — Sprive is the free app that helps take years off your mortgage and save you thousands of pounds in interest.
Capably AI — Capably empowers professionals to automate complex tasks with AI in minutes, regardless of their level of technical expertise. Operating autonomously in the background, Capably acts as an extension of the teams it supports, driving greater productivity and efficiency. Anyone in the company can use Capably to automate back-office tasks like dataentry and processing, generate insights and reports, manage projects, and more—all while the organisation maintains complete control and visibility over how and when employees delegate work to AI.
Liquid Acquire — Liquid Acquire provides AI solutions for mergers and acquisitions.

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Investment focus

Software, Health Care, Analytics
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

UltraSoC Technologies — UltraSoC Technologies is an independent provider of SoC infrastructure to enable rapid development of embedded systems based on advanced SoC devices. Its head office is in Cambridge and it has research and development labs in Colchester.
Intent HQ — Transform your understanding of customers with Intent HQ's Customer AI analytics and insights. Discover our cutting-edge platform and unlock new opportunities. Learn more now.
Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.

Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Funding Round
United Kingdom, Ireland, United States

Portfolio highlights

RETìníZE — RETìníZE is an AR, VR, multi-screen installations, and software development.
Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Liquid Acquire — Liquid Acquire provides AI solutions for mergers and acquisitions.

We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors

Investment focus

Health Care, Biotechnology, Manufacturing
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Investment focus

Health Care, Software, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Angoka — ANGOKA is an IoT security company focused on protecting M2M communications for Smart Cities and Mobility. Headquartered in Belfast, with offices in London and The Hague, ANGOKA offers solutions that protect devices’ identities. With an increase of inherently insecure networks coming online with the boom of IoT, ANGOKA’s solutions safeguard criticalmachine-to-machine communication integrity and data provenance, creating trusted connections, even in untrustworthy networks.ANGOKA is the only cybersecurity company to win a place on Zenzic’s CAM Scale-Up Programme, delivered in partnership with Plug and Play. ANGOKA was also the first NI start-up to be selected for NCSC’s Cyber Accelerator, who reviewed and assessed ANGOKA’s technology. ANGOKA is also an alumnus of Seraphim Space Camp, Yes!Delft and TechNation Cyber 2.0. Finally, ANGOKA has been awarded several Innovate UK R&D projects, which focus on securing quantum communications (led by BT) and two drone projects.
CyberOwl — CyberOwl develops an innovative early warning system for attacks through real-time monitoring of high-value targets for malicious behavior. The technology, based on research shortlisted for the Lloyd’s Science of Risk Prize 2015, is aimed at addressing the challenges of increasingly anonymous and persistent threats to rapidly-expanding globalnetworks, particularly in the wake of Smart Cities and the Internet of Things. The system raises early warning on network assets for possible undesirable activity, by applying a Bayesian-based framework to systematically analyze indicators associated with early stages of such activity. This approach dramatically reduces the processing overheads of monitoring. The benefits to the security operation include scalability to networks exceeding 1 billion devices, providing earlier visibility of risk and improving prioritization and decision-making in deploying countermeasures. CyberOwl is developing its minimum viable product and is looking for two or three strategic industry design partners for validation, verification, and further development. The ideal design partner would provide access to real-world security problems in a large network, high-volume data environment.CyberOwl was founded on 2016 and is headquartered in London, England.
Kelda Technology — Kelda Technology is a British clean tech business that develops water-in-air shower products that halve water usage and water heating costs through patented shower technology. Kelda Technology has adapted cutting edge automotive and aerospace technology to produce a revolutionary “water-in-air” shower system that halves water use without any lossin performance. Water is broken into droplets to form a comfortable spray which is accelerated using a globally patented jet-type nozzle. Not only does it halve water costs, but also halves associated heating costs.The Kelda shower system holds appeal for a wide range of sectors, including gym and leisure, hotels and accommodation providers, healthcare, and maritime – all industries where water efficiency is key. The product has completed in-market validation and commercial trials, is in manufacture and the company has already signed installation deals with some of the largest leisure operators in the UK and Latin America.Kelda Technology was recently chosen as one of the top 30 cleantech companies in the world at the New Energy Start-Up awards 2016 and was this week shortlisted by the UK Business Angels Association for Best Investment in a Disruptive Tech Business.

Innovate UK is part of the UK Research and Innovation .

Investment focus

Health Care, Biotechnology, Software
Grant, Seed, Pre-Seed
United Kingdom, United States, Canada

Portfolio highlights

Infleqtion — Infleqtion delivers high-value quantum information precisely where needed. Based on ColdQuanta's pioneering quantum research, their Edge-based products offer unmatched precision and power. Addressing critical needs in PNT, global communication security, energy distribution, and quantum computing, In
Open Data Institute — The Open Data Institute will catalyse the evolution of an open data culture to create economic, environmental, and social value. It will unlock supply, generate demand, create and disseminate knowledge to address local and global issues.The Open Data Institute will convene world-class experts to collaborate, incubate, nurture and mentor newideas, and promote innovation. We will enable anyone to learn and engage with open data, and empower our teams to help others through professional coaching and mentoring.Founded by Sir Tim Berners-Lee and Professor Nigel Shadbolt, the ODI is an independent, non-profit, non-partisan, limited by guarantee company.The ODI has secured £10 million over five years from the UK Government (via the UK innovation agency, the Technology Strategy Board), and $750,000 from Omidyar Network, and is working towards long-term sustainability through match funding and direct revenue.With a 5,000 sq ft convening space based in the heart of London's thriving Shoreditch area, and a global remit, we invite everyone intrested in developing Open Data to get in touch.
Symbiosis Pharmaceutical Services — Symbiosis Pharma is a biologics CMO offering rapid access to aseptic fill finish manufacturing slots across vaccines, ATMPs, mAbs & more

Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.

Investment focus

Software, Health Care, Financial Services
Seed, Series A, Secondary Market
United Kingdom, Germany, United States

Portfolio highlights

HeadBox — HeadBox is a new online marketplace for creative, inspiring and offsite spaces. They are the first platform in the UK to directly link their Guests (corporate and SME bookers) to their Hosts (owners of those creative, inspiring spaces) allowing you to instantly search, book and pay in an easy and seamless way saving time and hassle when planning aSpace experience.
GoodFit — Implement & scale any GTM strategy. Commercial Leaders use GoodFit to configure the data they need, to fuel their GTM strategy of choice
Merit Incentives — Seamless, API-driven solutions connecting you to a global network of 7,000+ brands, enabling real-time, instant gratification across 155+ countries.

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Italy, Germany

Portfolio highlights

ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
QV Bioelectronics — Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Investment focus

Biotechnology, Therapeutics, Health Care
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Ryme Medical — Ryme Medical is a device company developing a novel catheter-based treatment for COPD
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United Kingdom, United States, Ireland

Portfolio highlights

Sortera Bio — Sortera Bio operates as a biotechnology company. Sortera is committed to providing revolutionary solutions in biologics discovery.
T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates

The opportunity for institutional investors to access leading UK early stage healthtech businesses

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

TidalSense — CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
Baby2Body — Nearly 3 million women have used Baby2Body during their fertility, pregnancy, and postpartum journeys. Helping women around the world live healthier and happier with personalized fitness, nutrition, and wellness programs.

Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Private Equity, Seed
United Kingdom, United States, Ireland

Portfolio highlights

Ruleguard — Ruleguard is an regulatory technology platform for financial sector firms that helps you manage and evidence compliance across your organisation. Features include automated horizon scanning, rules mapping, SMCR compliance, third party oversight tools, breach management and regulatory checklists.
Fresh Car Valeting — Highly experienced professional mobile car body repairs, valeting and detailing auto repair services operating all over the UK. A complete mobile car care service, we can clean your car anywhere that you can park it.
Oxford Space Systems — Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS'structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. .

Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
United Kingdom, Ireland, Australia

Portfolio highlights

Peak — Accelerating AI adoption in retail and manufacturing, driving growth through inventory optimisation, AI-driven pricing, and more.
OBT Live — OBT Live helps brands in media, sport, retail and leisure drive sales and increase brand loyalty among consumers through AI.
Patchwork — NHS workforce solution for managing rotas, bank shifts, and staffing. Trusted by 200+ organisations. Built by healthcare professionals.

Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Series A, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

BioCorteX — BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and de-risk the pharma pipeline by leveraging the synergy between drugs and bacteria
Juno — Meet Juno, a workplace wellbeing programme that you control.
Milvus Advanced — Our Midas-touch alloys replicate the functional properties of platinum-group metals at a fraction of the cost.

Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round, Series A
United Kingdom

Portfolio highlights

Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Excelsior Sciences — Rebuilding the World, From the Bottom Up

MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.

Investment focus

Health Care, Software, Manufacturing
Debt Financing, Seed, Funding Round
United Kingdom, United States, Thailand

Portfolio highlights

Ekkosense — AI driven data center optimization software. Remove thermal risk, cut data center cooling costs and address data center cooling optimization
WELL Training — We deliver state of the art training solutions to national and international clients, transforming futures and delivering business growth through UK Apprenticeship and Commercial Training programmes.
Linear Diagnostics — Sexually transmitted infection management. Our innovative technology using EXPAR and Linear Dichroism provides the results in under 15 minutes

FSE C.I.C. is an independent not-for-profit Community Interest Company (C.I.C.) whose surpluses are reinvested in the business, rather than being driven by the need to maximise profit for shareholders and owners. FSE C.I.C. has a number of subsidiary companies to deliver its funds and services, which are collectively referred to as The FSE Group.All regulated activities are delivered through FSE Fund Managers Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment focus

Software, Information Technology, Manufacturing
Seed, Debt Financing, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

Sendr — Sendr uses AI to enhance sales outreach with personalized messages and data-driven tools for higher buyer engagement.
Quintex — We provide energy saving and grease management solutions for industrial kitchens, over 8,000 systems installed in the UK and Europe in a variety of sectors.
Grace & Green — Grace & Green fight for access, inclusivity, and education, dismantling barriers to essential care. Because dignity shouldn't come with a price.

The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series B
United Kingdom, France

Portfolio highlights

HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Funding Round
United Kingdom, United States, The Netherlands

Portfolio highlights

Aibuild — Ai Build is a London based company developing Artificial Intelligence and Robotic technologies for large scale additive manufacturing. We believe additive manufacturing is the core technology for achieving a sustainable environment and a highly efficient on-demand economy.We are a team of creative and enthusiastic people with strong background inthe areas of 3D printing, robotics, computer vision, machine learning, computational design and physics. We are partnering with some of the world’s most innovative companies and investors to bring our disruptive Autonomous Large Scale 3D Printing technology into a wide range of industrial applications. Our purpose is to empower factories of the future to make Manufacturing easy, smart, sustainable and affordable.
DaltonTx — DaltonTx platform provides pharma, biotech, and CROs with the intelligence backbone that modern R&D and redefining how technology powers drug discovery.
ToffeeX — ToffeeX: Physics-driven generative design software crafts optimized designs in hours. Set goals, let physics shape your components. Get a demo now!

We ensure that businesses in Northern Ireland with growth aspirations can access equity finance to reach their potential.

Investment focus

Software, Health Care, Health Diagnostics
Seed, Funding Round, Series A
United Kingdom, United States, Ireland

Portfolio highlights

Fluid Focus — Take control of your screen time and build better focus habits. Join thousands already reclaiming their time and attention; all whilst earning real-world rewards.
Liquid Acquire — Liquid Acquire provides AI solutions for mergers and acquisitions.
Cumulus Neuroscience — Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.

Midven is a specialist venture capital company providing investment to fast growing small and medium sized enterprises ("SMEs"), run by an energetic, experienced and hands-on team of investment managers.

Investment focus

Software, Manufacturing, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Eyoto — The future of eyecare technology, advanced tele-optometry solutions for the global optical industry. Creators of the world's first remote digital slit lamp.
Online Poundshop — Online Poundshop is an online-only, 24 hour, single priced retailer.Since launch in February 2014, Poundshop.com has created a new online shopping solution for customers keen to take advantage of pound shop savings. The huge range of everyday household essentials including cleaning products, batteries, toiletries, kitchen items, snacks, treatsand toys is now available with the convenience of home delivery. We are based in Exeter, Devon.In October 2014, the managerial and marketing teams of the UK’s 2 premier online single price retailers, Poundshop.com and Hereforapound.com joined forces. More exciting plans are only a few clicks away starting with our brand new look website and bigger than ever range of pound shop favourites!
Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.

Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors

Investment focus

Biotechnology, Medical Device, Health Care
Funding Round, Seed, Series A
United Kingdom, Germany, Philippines

Portfolio highlights

Kinomica — Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage.
Biofidelity — Unleashing the potential of genomics to transform the world we live in through transformational technologies that remove the noise from genomic analysis.
Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Seed
United Kingdom, United States, Switzerland

Portfolio highlights

Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
Purespring Therapeutics — A precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function.
Resolution Therapeutics — Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.